Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Cue Biopharma (CUE)
Technical Analysis Report for USA stock CUE Cue Biopharma. Dated: 30 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma then click here. or read Experts views on Cue Biopharma or Forecast & share price targets of Cue Biopharma
Cue Biopharma Opened at 20.66 and Closed at: 20.87, which is -2.78% of previous session's close. It moved within a range of 19.85 and 21.17
The session was a Bullish session with an average volume of 60700, which is -55.85% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 20.36 and resistance for tomorrow is 21.68
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 20.09, 19.31 resistance for tomorrow's hourly charts is 21.41, 21.95
10 Day SMA for Cue Biopharma (CUE) is 18.98 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Cue Biopharma (CUE) is 20.4 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Cue Biopharma (CUE) is 25.53 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 27.43 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Cue Biopharma is 18.14 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Cue Biopharma is at 20.4 and 200 DMA is at 18.14, while 50 DMA and 100 DMA are at 25.53 and 27.43 respectively
Cue Biopharma (CUE) moving average of 20 SMA is at 20.4 and 20 EMA is at 21.08
| Date | Closing Price | 20 SMA | 20 EMA |
| 30 Fri Oct | 20.87 | 20.4 | 21.08 |
| 29 Thu Oct | 21.45 | 20.63 | 21.1 |
| 28 Wed Oct | 21.16 | 20.82 | 21.06 |
| 27 Tue Oct | 18.23 | 21.06 | 21.05 |
| 26 Mon Oct | 18.45 | 21.42 | 21.35 |
| 23 Fri Oct | 18.66 | 21.87 | 21.65 |
Cue Biopharma (CUE) moving average of 50 SMA is at 25.53 and 50 EMA is at 23.98
| Date | Closing Price | 50 SMA | 50 EMA |
| 30 Fri Oct | 20.87 | 25.53 | 23.98 |
| 29 Thu Oct | 21.45 | 25.6 | 24.11 |
| 28 Wed Oct | 21.16 | 25.7 | 24.22 |
| 27 Tue Oct | 18.23 | 25.79 | 24.34 |
| 26 Mon Oct | 18.45 | 25.98 | 24.59 |
| 23 Fri Oct | 18.66 | 26.29 | 24.84 |
Cue Biopharma (CUE) moving average of 100 SMA is at 27.43 and 100 EMA is at 24.03
| Date | Closing Price | 100 SMA | 100 EMA |
| 30 Fri Oct | 20.87 | 27.43 | 24.03 |
| 29 Thu Oct | 21.45 | 27.5 | 24.09 |
| 28 Wed Oct | 21.16 | 27.59 | 24.14 |
| 27 Tue Oct | 18.23 | 27.67 | 24.2 |
| 26 Mon Oct | 18.45 | 27.78 | 24.32 |
| 23 Fri Oct | 18.66 | 27.9 | 24.44 |
Cue Biopharma (CUE) moving average of 200 SMA is at 18.14 and 200 EMA is at 19.77
| Date | Closing Price | 200 SMA | 200 EMA |
| 30 Fri Oct | 20.87 | 18.14 | 19.77 |
| 29 Thu Oct | 21.45 | 18.04 | 19.76 |
| 28 Wed Oct | 21.16 | 17.93 | 19.74 |
| 27 Tue Oct | 18.23 | 17.83 | 19.73 |
| 26 Mon Oct | 18.45 | 17.74 | 19.75 |
| 23 Fri Oct | 18.66 | 17.65 | 19.76 |
Teleflex Incorporated has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Teleflex Incorporated, about 25.93% more returns!
Stryker Corporation has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Stryker Corporation, about 16.47% more returns!
Prestige Consumer has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Prestige Consumer, about 21.92% more returns!
Msa Safety has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Msa Safety, about 11.84% more returns!
Mednax Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Mednax Inc, about 28.58% more returns!
Iqvia Holdings has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Iqvia Holdings, about 14.8% more returns!
Elanco Animal has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Elanco Animal, about 16.77% more returns!
Orasure Technologies has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Orasure Technologies, about 10.19% more returns!
Moderna Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Moderna Inc, about 23.45% more returns!
Moleculin Biotech has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Moleculin Biotech, about 1560.16% more returns!
Exelixis Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Exelixis Inc, about 32.24% more returns!
Eloxx Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Eloxx Pharmaceuticals, about 1.61% more returns!
Cue Biopharma has performed better than Dermira Inc in short term. Holding Cue Biopharma could be a better choice for now!
Cryolife Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Cryolife Inc, about 6.64% more returns!
Crispr Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 3.97% more returns!
Cue Biopharma has performed better than Accuray Incorporated in short term. Holding Cue Biopharma could be a better choice for now!
Cue Biopharma has performed better than Abeona Therapeutics in short term. Holding Cue Biopharma could be a better choice for now!
Cue Biopharma Technical analysis of indicators
Price action analysis of Cue Biopharma (CUE) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Cue Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Cue Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Cue Biopharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 18.76 and Cue Biopharma CUE stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cue Biopharma CUE stock. Volume based technical analysis of Cue Biopharma CUE stock is negative.
Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CUE Experts View which covers a lot of information including buying and selling signals
CUE future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cue Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


